Author Correction: Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease

Affiliations

• ¹ Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
• ² Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, IN, USA.
• ³ Department of Biomedical Informatics, College of Medicine, Ohio State University, Columbus, OH, USA.
• ⁴ Center for Therapeutics Discovery, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
• ⁵ Harrington Discovery Institute, University Hospitals Case Medical Center, Cleveland, OH, USA.
• ⁶ Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA.
• ⁷ Geriatric Research Education and Clinical Centers, Louis Stokes Cleveland VAMC, Cleveland, OH, USA.
• ⁸ Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
• ⁹ Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. chengf@ccf.org.
• ¹⁰ Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA. chengf@ccf.org.
• ¹¹ Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA. chengf@ccf.org.